Related Experiment Video
Updated: May 2, 2026

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer
Francesco De Sanctis1, Sara Sandri1, Giovanna Ferrarini1
1Immunology Section, Department of Pathology and Diagnostics, University of Verona , Verona , Italy.
Abstract:
Under many inflammatory contexts, such as tumor progression, systemic and peripheral immune response is tailored by reactive nitrogen species (RNS)-dependent post-translational modifications, suggesting a biological function for these chemical alterations. RNS modify both soluble factors and receptors essential to induce and maintain a tumor-specific immune response, creating a "chemical barrier" that impairs effector T cell infiltration and functionality in tumor microenvironment and supports the escape phase of cancer. RNS generation during tumor growth mainly depends on nitric oxide production by both tumor cells and tumor-infiltrating myeloid cells that constitutively activate essential metabolic pathways of l-arginine catabolism. This review provides an overview of the potential immunological and biological role of RNS-induced modifications and addresses new approaches targeting RNS either in search of novel biomarkers or to improve anti-cancer treatment.
Insights
Reactive nitrogen species (RNS) create a "chemical barrier" impairing anti-tumor immunity. Targeting RNS may offer new strategies for cancer treatment and biomarker discovery.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Reactive nitrogen species (RNS) are implicated in immune responses during tumor progression.
- RNS-dependent post-translational modifications suggest a functional role in immune regulation.
- These modifications can create a barrier hindering anti-tumor immunity.
Purpose of the Study:
- To review the immunological and biological roles of RNS-induced modifications in cancer.
- To explore novel therapeutic strategies targeting RNS in cancer treatment.
- To identify RNS as potential biomarkers for cancer immunotherapy.
Main Methods:
- Literature review of RNS in cancer immunology.
- Analysis of RNS generation pathways (e.g., nitric oxide production, l-arginine catabolism).
- Discussion of RNS-mediated post-translational modifications of immune factors.
Main Results:
- RNS modifications impair effector T cell infiltration and function within the tumor microenvironment.
- Tumor cells and myeloid cells are key sources of RNS during tumor growth.
- RNS contribute to immune evasion by cancer cells.
Conclusions:
- RNS play a significant role in modulating the anti-tumor immune response.
- Targeting RNS presents a promising avenue for improving cancer therapies.
- Further research into RNS modifications could yield novel cancer biomarkers.
More Related Videos
08:12Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins
Published on: January 8, 2018
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Mitogens and the Cell Cycle
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....